High-density lipoproteins, inflammation and oxidative stress

被引:133
|
作者
Tabet, Fatiha [1 ]
Rye, Kerry-Anne [1 ,2 ,3 ]
机构
[1] Heart Res Inst, Lipid Res Grp, Camperdown, NSW 2050, Australia
[2] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia
[3] Univ Melbourne, Dept Med, Melbourne, Vic 3065, Australia
基金
英国医学研究理事会;
关键词
antioxidant; cholesterol; coronary heart disease; high-density lipoprotein (HDL); inflammation; APOLIPOPROTEIN-A-I; PHOSPHOLIPID TRANSFER PROTEIN; ADHESION MOLECULE EXPRESSION; REVERSE CHOLESTEROL TRANSPORT; CORONARY-ARTERY-DISEASE; ESTER TRANSFER PROTEIN; LIPOPOLYSACCHARIDE-BINDING PROTEIN; RANDOMIZED CONTROLLED-TRIAL; SUPEROXIDE ANION PRODUCTION; E-DEFICIENT MICE;
D O I
10.1042/CS20080106
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Plasma levels of HDL (high-density lipoprotein)-cholesterol are strongly and inversely correlated with atherosclerotic cardiovascular disease. Both clinical and epidemiological studies have reported an inverse and independent association between serum HDL-cholesterol levels and CHD (coronary heart disease) risk. The cardioprotective effects of HDLs have been attributed to several mechanisms, including their involvement in the reverse cholesterol transport pathway. HDLs also have antioxidant, anti-inflammatory and antithrombotic properties and promote endothelial repair, all of which are likely to contribute to their ability to prevent CHD. The first part of this review summarizes what is known about the origins and metabolism of HDL. We then focus on the anti-inflammatory and antioxidant properties of HDL and discuss why these characteristics are cardioprotective.
引用
收藏
页码:87 / 98
页数:12
相关论文
共 50 条
  • [21] High-Density Lipoprotein and Atherosclerosis Regression Evidence From Preclinical and Clinical Studies
    Feig, Jonathan E.
    Hewing, Bernd
    Smith, Jonathan D.
    Hazen, Stanley L.
    Fisher, Edward A.
    CIRCULATION RESEARCH, 2014, 114 (01) : 205 - 213
  • [22] Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease
    Besler, Christian
    Luescher, Thomas F.
    Landmesser, Ulf
    EMBO MOLECULAR MEDICINE, 2012, 4 (04) : 251 - 268
  • [23] High-density lipoproteins (HDL): Novel function and therapeutic applications
    Darabi, Maryam
    Kontush, Anatol
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2022, 1867 (01):
  • [24] High-density lipoproteins during sepsis: from bench to bedside
    Tanaka, Sebastien
    Couret, David
    Tran-Dinh, Alexy
    Duranteau, Jacques
    Montravers, Philippe
    Schwendeman, Anna
    Meilhac, Olivier
    CRITICAL CARE, 2020, 24 (01)
  • [25] High-Density Lipoprotein Quantity or Quality for Cardiovascular Prevention?
    Calabresi, Laura
    Gomaraschi, Monica
    Franceschini, Guido
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (13) : 1494 - 1503
  • [26] The pleiotropic effects of high-density lipoproteins and apolipoprotein A-I
    Thomas, Shane R.
    Zhang, Yunjia
    Rye, Kerry-Anne
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 37 (03)
  • [27] The Role of High-Density Lipoproteins in Diabetes and Its Vascular Complications
    Wong, Nathan K. P.
    Nicholls, Stephen J.
    Tan, Joanne T. M.
    Bursill, Christina A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (06)
  • [28] Sphingomyelin in High-Density Lipoproteins: Structural Role and Biological Function
    Martinez-Beamonte, Roberto
    Lou-Bonafonte, Jose M.
    Martinez-Gracia, Maria V.
    Osada, Jesus
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (04) : 7716 - 7741
  • [29] High-Density Lipoproteins in the Prevention of Cardiovascular Disease: Changing the Paradigm
    Tuteja, S.
    Rader, D. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (01) : 48 - 56
  • [30] Health benefits of high-density lipoproteins in preventing cardiovascular diseases
    Berrougui, Hicham
    Momo, Claudia N.
    Khalil, Abdelouahed
    JOURNAL OF CLINICAL LIPIDOLOGY, 2012, 6 (06) : 524 - 533